Resources

Eligibility check tools

Please use the following tools to check whether:

• The regularly dosed biologic for RA, JIA, PsA or axSpA that a woman has been prescribed is a biologic which is included in MAMA
• (If applicable) the country that a woman plans to move in the first 6 months after birth with their infant has a high rate of tuberculosis (incidence >40 per 100,000 population)

List of regularly dosed biologic (including the listed reference medicinal product and biosimilars) for RA, JIA, PsA, or axSpA

If you cannot find the drug a woman has been prescribed in this list please contact the MAMA Study Team.

Source: MAMA IMP List Reference Drugs and Biosimilars v1.0 13Nov2024

List of countries with a high rate of tuberculosis (incidence >40 per 100,000 population)

If a woman plans to move with her infant to live in one of the countries on this list in the first 6 months after birth she is not eligible for the MAMA Study.

Source: Countries with over 40 per 100K TB, 2022 - WHO